If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

  • This share is currently suspended. It was suspended at a price of 164.40
  • There is currently no data for APAX

Director/PDMR Shareholding

17 Sep 2015 15:10

RNS Number : 4201Z
Apax Global Alpha Limited
17 September 2015
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES OR TO "US PERSONS" (AS DEFINED IN REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT")) OR INTO OR WITHIN AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN. RECIPIENTS OF THIS ANNOUNCEMENT IN JURISDICTIONS OUTSIDE THE UK SHOULD INFORM THEMSELVES ABOUT AND OBSERVE ANY APPLICABLE LEGAL REQUIREMENTS IN THEIR JURISDICTIONS. IN PARTICULAR, THE DISTRIBUTION OF THE ANNOUNCEMENT MAY BE RESTRICTED BY LAW IN CERTAIN JURISDICTIONS.

 

Note that any references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". Any references to Apax Partners LLP have been abbreviated to "Apax Partners" or "the Investment Adviser"

 

17 September 2015

FOR IMMEDIATE RELEASE

 

Apax Global Alpha Limited

Notice of Transactions of Persons Discharging Managerial Responsibilities ("PDMRs")

 

This notification is made in accordance with DTR 3.1.4R(1)(a) of the Disclosure and Transparency Rules.

 

Transfer of Shares

 

The Company has been informed on 17 September 2015, that John Megrue, an employee of Apax Partners and a person discharging managerial responsibilities, has transferred 4,578,805 ordinary shares of no par value in the Company (the "Ordinary Shares") to Lizanne Megrue (the "Transfer").

 

No consideration was paid for the Transfer. The Ordinary Shares transferred remain subject to the same lock-up arrangements agreed in connection with the Company's IPO on 15 June 2015, details of which are summarised in the Company's prospectus dated 21 May 2015, available on the Company's website.

 

The Transfer is unconnected to the Company and forms part of a domestic transfer between John Megrue and Lizanne Megrue. The beneficial interest to the Ordinary Shares transferred is held by Lizanne Megrue.

 

Investor Relations

Lorraine Rees

 

Telephone:

+44 (0)20 7872 6300

Email:

investor.relations@apaxglobalalpha.com

 

Media enquiries (Apax Global Alpha Limited)

Alex Jones

 

Telephone:

+44 (0)20 7952 2000

Email:

aga@greenbrookpr.com

 

Media enquiries (Apax Partners LLP)

Alex Wessendorff

 

Telephone:

+44 (0)20 7872 6461

Email:

alex.wessendorff@apax.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBSGDCCGBBGUR
Date   Source Headline
8th Mar 20167:00 amRNSDividend Declaration
8th Mar 20167:00 amRNS2015 Annual Report and Audited Accounts
8th Mar 20167:00 amRNSFinal Results
24th Feb 20163:22 pmRNSDisclosure of Home Member State
12th Feb 20167:00 amRNSNotification of 2015 Annual Results
5th Feb 20167:00 amRNSApax Fund IX Commitment and RCF Renewal
25th Jan 20163:32 pmRNSApax Fund Valuations as at 31 December 2015
4th Nov 20157:00 amRNSQ3 2015 Market Update
19th Oct 20152:39 pmRNSApax Fund Valuations as at 30 September 2015
6th Oct 201512:24 pmRNSNotice of Q3 2015 Results
17th Sep 20153:10 pmRNSDirector/PDMR Shareholding
28th Aug 20153:10 pmRNSDirector/PDMR Shareholding
26th Aug 20157:00 amRNS2015 Interim Report and Accounts
26th Aug 20157:00 amRNS2015 Interim Highlights
22nd Jul 20157:00 amRNSAppointment of Director
17th Jul 20154:03 pmRNSApax Fund Valuations as at 30 June 2015
30th Jun 20153:32 pmRNSTotal Voting Rights
23rd Jun 20154:18 pmRNSHolding(s) in Company
22nd Jun 20153:11 pmRNSHolding(s) in Company
19th Jun 20157:00 amRNSHolding(s) in Company
19th Jun 20157:00 amRNSHolding(s) in Company
15th Jun 20158:00 amRNSAdmission to trading on the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.